Walleye Capital
BHVN icon

Walleye Capital’s Biohaven BHVN Stock Holding History

Walleye Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Sell
203,477
-650,947
-76% -$7.12M 0.01% 1594
2025
Q4 		$9.65M Buy
854,424
+783,569
+1,106% +$9.71M 0.03% 685
2025
Q3 		$1.06M Sell
70,855
-84,601
-54% -$1.23M ﹤0.01% 2042
2025
Q2 		$2.19M Buy
155,456
+152,218
+4,701% +$2.71M 0.01% 1436
2025
Q1 		$77.8K Buy
+3,238
New +$114K ﹤0.01% 3710
2024
Q3 		– Sell
-83,997
Closed -$2.92M – 5300
2024
Q2 		$2.92M Sell
83,997
-25,063
-23% -$991K 0.01% 1759
2024
Q1 		$5.96M Sell
109,060
-13,057
-11% -$647K 0.01% 1173
2023
Q4 		$5.29M Sell
122,117
-278,017
-69% -$8.65M 0.01% 1075
2023
Q3 		$10.4M Buy
400,134
+369,691
+1,214% +$7.68M 0.03% 550
2023
Q2 		$728K Buy
+30,443
New +$524K ﹤0.01% 2130

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return